Q3070648 (Q3070648): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes) |
(Created claim: summary (P836): The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services. (English) | |||||||||||||||
Property / summary: The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services. (English) / qualifier | |||||||||||||||
point in time: 16 August 2021
|
Revision as of 12:13, 16 August 2021
Project Q3070648 in Estonia
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3070648 in Estonia |
Statements
180,721.80 Euro
0 references
401,604.0 Euro
0 references
45.0 percent
0 references
1 October 2019
0 references
27 March 2021
0 references
Icosagen Cell Factory OÜ
0 references
61713
0 references
Icosagen Cell Factory arenguprogrammi tulemusena arendatakse välja produtsentrakuliinide arendusteenud kui toode ning viiakse ettevõtte digitaliseerimine ning personali teadlikkus oluliselt kõrgemale tasemele, mis tagab parema konkurentsivõime diagnostiliste antikehade arendamise ja efektiivse antikehade tootmisteenuse pakkumise turul. (Estonian)
0 references
The development program of Icosagen Cell Factory leads to the development of producer cell lines as a product and to a significantly higher level of company digitalisation and staff awareness, ensuring greater competitiveness in the market for the development of diagnostic antibodies and the provision of effective antibody production services. (English)
16 August 2021
0 references
Identifiers
2014-2020.4.04.19-1127
0 references